Your Health Questions
Answered by Professionals

Why do bipolar medications sometimes stop working? Several factors can drive treatment failure: complex brain biology, missed or delayed diagnosis, partial response or tolerance, dose-limiting side effects, and co-occurring conditions. Recommended next steps include a thorough psychiatric reassessment, adherence and prior-trial review, and medical screening with labs, sleep studies, and thyroid checks. Emerging options include ketamine or esketamine, neuromodulation such as TMS and ECT, long-acting injectables, and metabolic or anti-inflammatory adjuncts like omega-3, NAC, and metformin. Precision prescribing, strict sleep routines, and therapy also help—seek urgent care for suicidality or severe episodes. Because bipolar treatment failure has many overlapping causes, pinpointing what's driving your symptoms is the critical first step. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing and guide your next conversation with a provider. Reviewed for medical accuracy: 07/09/2026

Newer antipsychotics provide more targeted treatment when older medications fall short. They use partial dopamine agonism and act on multiple neurotransmitters, while long-acting injectables improve adherence and may better address persistent positive, negative, and cognitive symptoms with fewer movement-related side effects. Key next steps include: a full medication review, exploring injectable options for adherence, routine lab monitoring, adding therapy, addressing sleep and substance use, and considering clozapine for treatment-resistant cases. Below, you'll find expert details, urgent warning signs, and nuances that could change your treatment plan. Because symptoms and side effects vary widely from person to person, understanding your specific situation is critical before making treatment decisions. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing, identify red flags, and prepare informed questions for your clinician—so you can navigate next steps with confidence rather than guesswork. Reviewed for medical accuracy: 07/09/2026

When standard bipolar treatments fall short, several evidence-based options can help. Ketamine and esketamine offer rapid relief for severe depression, while TMS provides a non-invasive alternative. Modern ECT remains highly effective for treatment-resistant cases, and long-acting injectables improve adherence. Personalized medication combinations paired with CBT and IPSRT therapy can also stabilize mood patterns long-term. The right next step depends on your treatment history, side effects, relapse patterns, suicidality risk, and medication adherence. Because bipolar symptoms often overlap with other conditions—and choosing the wrong path can delay relief—it's critical to clarify what you're experiencing before your next psychiatry visit. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand your symptoms, identify possible causes, and walk into your appointment prepared to advocate for the safest, most effective plan. Reviewed for medical accuracy: 06/23/2026

Bipolar disorder treatment in 2026 has advanced significantly, giving people who still struggle with symptoms new options for meaningful relief. Emerging therapies include: - **Smarter dopamine-serotonin modulators** with fewer metabolic side effects - **Glutamate-based therapies** offering novel mechanisms of action - **Targeted treatments for bipolar depression**, a historically hard-to-treat phase - **Long-acting injectables** selected through more personalized, precision-based care Many of these newer medications feature less sedation, reduced weight gain risk, and sometimes a faster onset of action compared to older treatments. Key considerations include safety tradeoffs, who should discuss switching medications, how ongoing monitoring works, and when to seek urgent help. Understanding your specific symptoms is the essential first step before talking with your clinician. Because bipolar symptoms overlap with many other conditions—such as depression, ADHD, anxiety, or thyroid disorders—getting clarity on what you're experiencing matters. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify potential causes, prepare the right questions for your doctor, and confidently navigate next steps toward the right treatment plan for you. Reviewed for medical accuracy: 07/09/2026

The newest FDA-approved depression treatments in 2026 offer faster relief for people who haven't responded to standard antidepressants. Options include rapid-acting NMDA-targeted therapies like esketamine and the oral dextromethorphan-bupropion combination, along with expanded device-based care such as transcranial magnetic stimulation (TMS) and updated vagus nerve stimulation (VNS) targeting new brain regions. Tightly regulated psychedelic-inspired therapies are also emerging under strict clinical supervision. Before starting any new treatment, key factors to weigh include eligibility, safety monitoring, access, cost, insurance coverage, and how each option pairs with therapy for the best outcomes. Because depression symptoms overlap with many other conditions—and choosing the right treatment path depends on understanding what you're actually experiencing—it's worth getting clarity before your next doctor's visit. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand your symptoms, identify possible causes, and confidently navigate your next steps. Reviewed for medical accuracy: 07/09/2026

Struggling with bipolar disorder despite treatment? Next-generation bipolar medications offer more targeted mechanisms, better coverage of bipolar depression, and improved tolerability. These options include newer atypical antipsychotics, dopamine and serotonin stabilizers, glutamate-modulating drugs, and long-acting injectables. Below, learn who should consider switching medications, key side effects and monitoring requirements, adherence strategies, and how combining medication with therapy and structured routines can improve outcomes. Because bipolar symptoms often overlap with other conditions—and because the right treatment depends on an accurate picture of what you're experiencing—it's worth taking a few minutes to clarify your symptoms before your next appointment. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify patterns, rule out overlapping conditions, and prepare informed questions for your provider—empowering you to navigate next steps with confidence. Reviewed for medical accuracy: 07/09/2026

Bipolar disorder treatment is advancing rapidly, with the FDA pipeline delivering meaningful breakthroughs in 2025 and beyond. New options include rapid-acting therapies for bipolar depression that target glutamate pathways, long-acting injectables that improve medication adherence, targeted treatments for mixed episodes, and newer agents with fewer metabolic side effects. Emerging approaches also explore inflammation and circadian rhythm regulation, while recent FDA approvals are already expanding patient choices. Because every treatment carries unique benefits, risks, and warning signs, choosing the right path forward depends on your specific symptoms and history. Before your next appointment, take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to clarify what you're experiencing, identify urgent red flags, and prepare informed questions about newer therapies to discuss with your clinician. Reviewed for medical accuracy: 07/09/2026

Vagus nerve stimulation (VNS) shows increasing long-term benefits for treatment-resistant depression, according to new medical data spanning 1 to 5 years. Compared to treatment-as-usual, VNS delivers higher response and remission rates, and may reduce suicide risk in patients who have not improved with standard therapies. However, VNS is not a quick fix. It requires thorough screening, ongoing monitoring, and awareness of potential side effects. Non-implant alternatives, such as transcutaneous VNS, are also under active study and may suit patients seeking less invasive options. Understanding candidacy, timing, and expected outcomes is essential before pursuing this therapy. If you're experiencing persistent depression symptoms and wondering about your next steps, take a free, instant, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what may be driving how you feel. In under 3 minutes, you'll receive personalized insights based on your specific symptoms — helping you have a more informed, productive conversation with your clinician about whether advanced treatments like VNS could be right for you. Reviewed for medical accuracy: 07/10/2026

Refractory bipolar disorder is diagnosed when manic, depressive, hypomanic, or mixed symptoms persist despite at least two adequate medication trials. Common causes include misdiagnosis, subtherapeutic dosing, drug interactions, sleep disruption, rapid cycling or mixed features, substance use, and underlying medical issues like thyroid dysfunction or vitamin deficiencies. Effective next steps include optimizing mood stabilizers (such as lithium and combination regimens), targeted therapies for bipolar depression, and advanced treatments like clozapine, ketamine or esketamine, ECT, and TMS. Circadian rhythm–focused care and evidence-based psychotherapy also play a critical role. Specific labs, safety warnings, and decision pathways are outlined below. Because refractory bipolar disorder often stems from overlooked or misidentified factors, clarifying your symptoms is a vital first step. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what may be driving your symptoms and confidently navigate your next steps with your care team. Reviewed for medical accuracy: 07/10/2026

Atypical depression often persists due to several interconnected biological and emotional factors: altered stress hormones, disrupted dopamine reward responses, inflammation, metabolic shifts, and heightened rejection sensitivity. These overlapping systems can make symptoms resistant to standard treatment. Effective next steps include: - Getting a clear, accurate diagnosis - Discussing tailored medications (such as dopamine-targeting options or MAOIs) - Practicing behavioral activation - Tightening sleep timing with morning light exposure - Adopting anti-inflammatory lifestyle habits - Adding therapy and strong social support - Seeking urgent care if symptoms become severe or suicidal Because atypical depression involves so many overlapping systems, identifying your specific symptom pattern is essential to choosing the right treatment path. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's going on and confidently navigate your next steps. Reviewed for medical accuracy: 06/23/2026

Why does your brain resist mood disorder management? Common reasons include slow-to-shift brain chemistry, entrenched depressive thinking patterns, low energy, unresolved stress or trauma, and the need for treatment adjustments plus consistent follow-through. Practical next steps include reassessing your plan with a clinician, starting with smaller goals, protecting sleep, reducing isolation, and recognizing urgent warning signs that require immediate care. Understanding which factors apply to you can change which steps matter most in your healthcare journey. Because mood disorder symptoms often overlap with other conditions—and the right next step depends on what's actually driving them—it's worth getting a clearer picture before making changes. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify possible causes, prioritize concerns, and navigate next steps with more confidence. Reviewed for medical accuracy: 07/09/2026

Circadian rhythm disruption is one of the most overlooked drivers of ongoing bipolar mood swings. Aligning your sleep timing, light exposure, and daily routines can significantly lower relapse risk and improve long-term mood stability. Evidence-based next steps include Interpersonal and Social Rhythm Therapy (IPSRT), strict sleep protection with a fixed wake time, carefully supervised light therapy, reducing evening blue light, reviewing medication timing, and preparing for travel or seasonal changes—along with knowing when to seek urgent care. Because several personal factors can change your next steps, understanding your specific symptom pattern is critical. The fastest way to clarify what's driving your mood swings and what to do next is to take a free, instant, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a>. In just a few minutes, you'll get personalized insights based on your unique symptoms, helping you decide whether lifestyle adjustments, a specialist visit, or urgent care is the right next step—no signup required. Reviewed for medical accuracy: 07/10/2026

Depression biomarkers are measurable biological signals that help explain why symptoms persist and guide more personalized treatment. Key biomarkers include: - **Inflammation markers**: CRP and IL-6 - **Stress hormones**: Cortisol and HPA-axis measures - **Neurotrophic factors**: BDNF (brain-derived neurotrophic factor) - **Neurotransmitters**: Serotonin, dopamine, norepinephrine - **Gut health patterns**: Microbiome imbalances - **Related labs**: Thyroid panels, vitamin D, hormone levels While no single test can diagnose depression, these biomarkers can clarify unexplained symptoms, inform medication and therapy choices, and highlight urgent red flags requiring immediate care. Because symptoms of depression often overlap with thyroid disorders, chronic inflammation, hormonal imbalances, and other treatable conditions, understanding *what your body is signaling* is the critical first step. Before requesting specific lab panels or starting new treatments, it helps to map your symptoms against possible causes. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's driving how you feel and confidently navigate your next steps with a clinician. Reviewed for medical accuracy: 07/03/2026

When conventional Crohn's disease treatments fail, clinical trials offer promising experimental options, including next-generation biologics, targeted oral small molecules, stem cell therapies, microbiome-based treatments, and personalized medicine approaches—all administered under strict safety monitoring protocols. Before pursuing experimental therapies, it's essential to confirm active inflammation, understand eligibility criteria, weigh potential benefits against risks, prepare key questions for your gastroenterologist, and recognize warning signs requiring urgent care. Because Crohn's symptoms often overlap with other GI conditions, identifying what's actually driving your flare is the critical first step before exploring trial options. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms, better understand possible causes, and guide your next conversation with your gastroenterologist—saving you time and helping you make more informed treatment decisions. Reviewed for medical accuracy: 07/03/2026

Fecal microbiota transplant (FMT) trials are an emerging research-based option for irritable bowel syndrome (IBS) when standard treatments—diet changes, fiber, probiotics, medications, and stress management—fail to provide relief. FMT targets the gut microbiome, and early studies suggest some patients, particularly those with IBS-D (diarrhea-predominant), may benefit, though results remain mixed. Participating in a regulated clinical trial is far safer than seeking treatment at unregulated clinics. Key considerations include candidate eligibility, how trials are conducted and monitored, potential risks, and red-flag symptoms that may indicate other conditions. It's also essential to optimize standard IBS treatments before enrolling. Because IBS symptoms overlap with many other GI conditions, understanding your specific symptom pattern is a critical first step before pursuing advanced options like FMT. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what may be driving your symptoms, flag any warning signs, and guide your next steps—whether that's optimizing current care or exploring trial eligibility with your doctor. Reviewed for medical accuracy: 07/09/2026

Observational IBD studies track your usual care with low risk, while interventional trials test new therapies with closer monitoring, potential benefit, and added risks like possible placebo. The key difference is whether your treatment changes. Several factors shape your best next step: current symptom control, risk tolerance, and personal goals. Flaring patients may be better matched to interventional trials, while stable patients wanting to support research with minimal risk often prefer observational studies. Review safety red flags and questions to ask your doctor below. Because the right study depends heavily on how well your IBD is currently controlled, understanding your symptoms is the critical first step. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to clarify what's going on and confidently navigate your next steps with your care team. Reviewed for medical accuracy: 07/02/2026

Ongoing IBS symptoms may point to more than IBS. Common causes include incomplete testing, gut-brain miscommunication, microbiome imbalance, hidden food triggers, or low-grade inflammation that could indicate IBD. Recognizing red flags early is critical to avoid delayed diagnosis and complications. Today's IBD specialists use precise diagnostics and personalized treatment, including advanced medications, gut-directed therapies, targeted probiotic and diet strategies, and structured follow-up care. Knowing when to search for an "IBD specialist near me" can shorten your path to relief. Because IBS and IBD share overlapping symptoms but require very different care, clarifying your symptoms first is the smartest next step. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify red flags, understand possible causes, and confidently decide what to do next. Reviewed for medical accuracy: 07/09/2026

Living with Crohn's disease or ulcerative colitis that isn't responding to treatment? Mayo Clinic's IBD clinical trials offer research-backed access to emerging therapies, including new biologics, oral small molecules, microbiome-based treatments, and precision medicine strategies, all with close specialist monitoring. Eligibility depends on your specific diagnosis, current disease activity, and how you've responded to prior medications. Key factors to weigh include enrollment criteria, safety protocols and placebo use, potential benefits versus risks, urgent warning signs to watch for, and how to discuss trial participation with your gastroenterologist. Because IBD symptoms often overlap with other digestive conditions—and because trial eligibility hinges on accurately characterizing your symptoms and disease activity—it's smart to clarify what you're experiencing before your next GI appointment. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you organize your symptoms, identify possible causes, and walk into that conversation prepared to ask the right questions about clinical trial options. Reviewed for medical accuracy: 07/09/2026

Long-term data confirm modern Crohn's disease treatments are largely safe, with serious side effects remaining uncommon over years of use. Infections are a manageable risk when paired with proper screening and vaccinations. Anti-TNF therapies carry a small lymphoma risk, particularly when combined with thiopurines, while gut-selective options like vedolizumab and newer IL-12/23 and IL-23 inhibitors show reassuring safety profiles—reducing hospitalizations, surgeries, and steroid dependence. Before starting or adjusting Crohn's therapy, key factors to weigh include your age, history of infections or cancer, pregnancy plans, and whether you're using combination immunosuppression. Drug-by-drug risks vary, and knowing when to call your doctor is essential. If you're experiencing symptoms or unsure whether your current treatment is working, the fastest way to get clarity is to take a free, instant, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a>. In just a few minutes, you'll receive personalized insights based on your symptoms, helping you understand what may be going on and guiding your next steps—whether that's a conversation with your gastroenterologist or urgent care. It's private, no signup required, and could save you time navigating a complex condition like Crohn's. Reviewed for medical accuracy: 07/09/2026

Newer selective oral JAK inhibitors—including upadacitinib, filgotinib, and the TYK2 inhibitor deucravacitinib—may offer strong symptom relief with potentially fewer side effects than older JAK inhibitors. However, risks still vary based on age, cardiovascular and blood clot history, infection risk, and prior cancer diagnoses. Key next steps: - Confirm your diagnosis and current disease activity - Review vaccination status and baseline lab work - Talk with your rheumatologist about whether a newer JAK inhibitor, an alternative biologic, or combination therapy best fits your risk profile Because symptoms of autoimmune and inflammatory conditions often overlap—and because the right medication depends heavily on what's actually driving your symptoms—getting clarity early matters. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify possible causes, understand urgency, and prepare more informed questions for your rheumatologist. It takes only a few minutes, requires no signup, and can meaningfully shape your next conversation with your doctor. Reviewed for medical accuracy: 07/09/2026

IBD gene therapy is an emerging, research-stage treatment for Crohn's disease and ulcerative colitis that targets the genetic and immune drivers of inflammation more precisely than standard drugs. It uses methods like anti-inflammatory gene delivery, RNA-based silencing, and engineered microbiome therapies to address root causes rather than symptoms. While not yet standard care, gene therapy may offer longer-lasting relief for patients who don't respond to conventional treatments. Benefits, risks, and eligibility vary by patient and clinical trial, so review the complete details below to discuss options with your gastroenterologist—including clinical trial enrollment, genetic testing, and red-flag symptoms that require urgent care. If you're experiencing persistent abdominal pain, chronic diarrhea, rectal bleeding, or unexplained weight loss, don't wait to find answers. Understanding your symptoms is the first step toward the right treatment path—whether that's advanced therapy, a clinical trial, or standard care. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to clarify what may be driving your symptoms and get personalized guidance on next steps to discuss with your doctor. Reviewed for medical accuracy: 07/09/2026

The newest FDA-approved IBD drugs in 2026 expand treatment options for Crohn's disease and ulcerative colitis, including IL-23 inhibitors, next-generation JAK inhibitors, S1P modulators, and emerging dual-targeted therapies. These advances can improve remission rates, reduce steroid dependence, and offer more convenient oral options. Choosing the right medication depends on disease severity, prior treatment response, safety risks, and personal factors like pregnancy plans or insurance coverage. Talk with your gastroenterologist about which option fits you, how to prepare for your visit, and which urgent symptoms require immediate care. Because IBD symptoms often overlap with other GI conditions, understanding what's driving your flare is the critical first step before discussing new therapies. A free, instant <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify possible causes, clarify urgency, and walk into your appointment prepared with the right questions—so you and your doctor can move faster toward the treatment that fits. Reviewed for medical accuracy: 07/09/2026

Struggling with Crohn's disease or ulcerative colitis? Mount Sinai IBD research recruitment may provide access to emerging therapies, expert monitoring, and the chance to advance future care—often with study-related costs covered. Before enrolling, consider key factors: eligibility requirements, potential risks like side effects or placebo assignment, and how a trial fits alongside your current treatment plan. Always consult your gastroenterologist first. Review details below on who qualifies, what to expect, safety oversight, costs, and warning signs that require urgent care. Not sure if your symptoms point to Crohn's, ulcerative colitis, or something else? Understanding what's driving your discomfort is the critical first step before considering a clinical trial or changing your treatment. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to clarify your situation and confidently navigate your next steps with your doctor. Reviewed for medical accuracy: 07/09/2026

Emerging IL-12/23 inhibitors may offer a breakthrough for people still battling psoriasis, psoriatic arthritis, or inflammatory bowel disease (IBD). These next-generation biologics promise more precise targeting, longer-lasting relief with fewer injections, and higher rates of skin clearance—even in patients who have failed prior biologic therapies. Key considerations include how IL-12/23 inhibitors compare with IL-23-only options, and which patient profiles are most likely to benefit. Safety planning is essential: infection risks, tuberculosis screening, vaccination review, symptom tracking, and discussing clinical trial eligibility or therapy switches with your clinician. Because psoriasis, psoriatic arthritis, and IBD symptoms often overlap with other conditions—and because treatment decisions hinge on the specifics of your case—clarifying what's driving your symptoms is a smart first step. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify possible causes, understand urgency, and prepare focused questions for your doctor about whether newer IL-12/23 therapies could fit your treatment path. Reviewed for medical accuracy: 07/09/2026

Perianal Crohn's disease clinical trials provide regulated, physician-supervised treatment options when standard therapies fall short. These studies offer access to advanced biologics and innovative approaches like stem cell therapy, all under expert medical oversight, while contributing to future treatment approvals. Key considerations include: eligibility requirements, built-in safety safeguards, how a trial interacts with your current medications, and when to seek urgent care. Below, you'll find complete details, essential questions to ask your doctor, and practical next steps to guide your care plan. Because perianal Crohn's symptoms — such as fistulas, abscesses, drainage, and pain — often overlap with other conditions, understanding what's driving your symptoms is the critical first step before exploring trial options. A quick, guided assessment can help you clarify your situation, identify red flags, and prepare informed questions for your gastroenterologist. Take a free, instant, private <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's going on and confidently navigate your next steps. Reviewed for medical accuracy: 07/09/2026

Severe IBD treatments can fail for several reasons: primary nonresponse, loss of response due to low drug levels or anti-drug antibodies, incorrect or overlapping diagnoses, structural complications medication cannot reverse, and adherence or lifestyle triggers. Next clinical steps typically include objective testing and therapeutic drug monitoring, switching or combining therapies under a treat-to-target plan, advanced imaging, timely surgical consultation, and exploring clinical trials. Recognizing red flag symptoms and key decision points can significantly change your next move. Because IBD treatment failure has many overlapping causes, pinpointing which one applies to you is critical before your next appointment. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms, identify red flags, and walk into your next visit prepared with the right questions—saving time and potentially guiding faster, more effective care. Reviewed for medical accuracy: 07/10/2026

Inflammatory bowel disease (IBD) is an autoimmune condition that causes persistent gut inflammation, and 30–40% of patients don't achieve lasting remission on first-line therapies due to loss of response, side effects, or aggressive disease progression. Clinical trials may offer access to advanced treatments and close monitoring, but they carry real risks: potential placebo assignment, disease worsening, unknown side effects, medication restrictions, and demanding visit schedules. Before enrolling, review the trial phase, rescue protocols, cost coverage, alternatives, and warning signs requiring urgent care—and discuss thoroughly with your doctor. Because IBD symptoms overlap with many other conditions and flare patterns vary widely, understanding what you're experiencing is the critical first step. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms, identify possible causes, and guide your next conversation with a specialist—so you can make informed decisions about treatment or trial participation. Reviewed for medical accuracy: 07/10/2026

Ongoing ulcerative colitis symptoms despite optimized mesalamine and steroids can signal several issues: inadequate rectal drug delivery, undertreatment, poor adherence, steroid dependence, disease extension, or infection (such as C. difficile or CMV). Objective reassessment—including endoscopy, imaging, biomarkers (fecal calprotectin, CRP), and stool studies—is essential before escalating therapy. Advanced treatment options include biologics (anti-TNF agents like infliximab or adalimumab, vedolizumab, ustekinumab), oral small molecules (JAK inhibitors such as tofacitinib or upadacitinib, and ozanimod), and investigational therapies through clinical trials. Because persistent symptoms may stem from many overlapping causes, identifying the right next step starts with understanding your specific symptom pattern. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to clarify what may be driving your symptoms and guide informed conversations with your care team. Reviewed for medical accuracy: 07/09/2026

Why am I still having symptoms on infliximab? Several factors can explain ongoing symptoms, and understanding them helps guide next steps. The most common fixable cause is a low infliximab trough level (target typically ≥5 µg/mL for IBD, higher in fistulizing disease). Low levels often result from rapid drug clearance due to active inflammation, anti-drug antibodies, or under-dosing—all of which therapeutic drug monitoring (TDM) can identify. Based on results, options include increasing the dose, shortening infusion intervals, adding an immunomodulator, or switching biologics. If trough levels are adequate, non-inflammatory causes (infection, bile acid diarrhea, IBS overlap, strictures) should be evaluated. Urgent red flags—fever, severe abdominal pain, obstruction symptoms, heavy bleeding, or new neurologic changes—warrant immediate medical attention. Because "still symptomatic on infliximab" can stem from very different causes—each with a different fix—clarifying your specific pattern is the fastest way to get answers. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you organize your symptoms, flag urgent concerns, and prepare focused questions for your gastroenterologist, so your next visit leads to real change rather than another wait-and-see. Reviewed for medical accuracy: 07/09/2026

Why does bipolar disorder remain unstable for some people? Persistent instability in **Bipolar 1 vs Bipolar 2** often points to a missed diagnosis or incorrect subtype, suboptimal medication choice or dosing, poor adherence, sleep disruption, substance use, or untreated co-occurring conditions like anxiety or ADHD. Effective next steps include confirming the correct subtype, optimizing mood stabilizers before adding antidepressants, incorporating structured psychotherapy, consistently tracking sleep and mood, and discussing lifestyle changes or advanced options with a specialist. Recognizing subtype differences and urgent warning signs is critical to knowing what to do next. Because symptoms of Bipolar 1 and Bipolar 2 overlap with depression, anxiety, and ADHD, self-identifying the right pattern is difficult—and the wrong path delays relief. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what you're experiencing, flag urgent warning signs, and guide your next conversation with a clinician. Reviewed for medical accuracy: 06/23/2026